Treatments

Application (AVG)

N

P

K

Ca

Mg

Na

Control

B

30.89 ± 1.89 c

24.71 ± 1.99 c

46.50 ± 6.77 e

51.79 ± 3.54 d

4.45 ± 0.46 d

5.90 ± 0.86 e

B + F

CF

B

325.52 ± 12.42 a

138.58 ± 11.73 a

321.02 ± 15.61 d

227.00 ± 27.20 b

14.56 ± 1.38 ab

74.51 ± 10.35 a

B + F

SLF1

B

248.85 ± 13.35 b

108.82 ± 8.99 b

394.52 ± 28.72 c

180.83 ± 15.55 c

10.87 ± 1.36 c

23.68 ± 4.66 d

B + F

SLF2

B

317.84 ± 12.25 a

123.11 ± 7.83 ab

425.96 ± 10.13 ab

233.93 ± 23.79 ab

15.73 ± 2.31 a

59.03 ± 7.95 b

B + F

SLF3

B

279.14 ± 28.31 b

126.99 ± 8.80 a

437.28 ± 9.21 a

207.98 ± 13.52 bc

12.40 ± 0.66 bc

20.20 ± 5.98 d

B + F

SLF4

B

325.78 ± 22.03 a

132.83 ± 9.44 a

401.55 ± 14.49 bc

265.45 ± 17.47 a

17.17 ± 1.01 a

39.97 ± 7.67 c

B + F

Source of variance

Treatments

26.66**

17.53**

33.24**

35.85**

2.46**

12.88**

Application method

ns

ns

ns

ns

0.95*

ns

Interaction (T × A)

ns

ns

ns

ns

ns

ns

CV%

7.3

8.93

5.47

10.25

10.92

19.64